The main pathogenetic process in androgenetic alopecia is dihydrotestosterone-mediated follicular miniaturization in androgen-dependent scalp areas. Differential diagnosis is complex, especially in women, and covers a broad spectrum of non-cicatricial and cicatricial alopecias, particularly telogen effluvium and frontal fibrosing alopecia. The basic additional diagnostic procedure is trichoscopy. Currently there are two drugs approved for the treatment of androgenetic alopecia: minoxidil (in men and women) and finasteride (in men). However, medical literature indicates significantly more therapeutic options. The article presents algorithms recommended for the management of androgenetic alopecia in women and men.